Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 700-706 , March 2010

Circulation levels of acute phase proteins in patients with Takayasu arteritis

Received 29 June 2009 ,Accepted 12 September 2009.

References 

  1. Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet. 2000;356:1023–1025
  2. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481–486
  3. Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008;118:2738–2747
  4. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM, et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg. 2006;43:64–71
  5. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454
  6. Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54(suppl):S141–S147
  7. Hoffman GS. Takayasu arteritis: lessons from the American National Institutes of Health experience. Int J Cardiol. 1996;54(suppl):S99–S102
  8. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(suppl):S155–S163
  9. Arnaud L, Kahn JE, Girszyn N, Piette AM, Bletry O. Takayasu's arteritis: an update on physiopathology. Eur J Intern Med. 2006;17:241–246
  10. Pajari R, Hekali P, Harjola PT. Treatment of Takayasu's arteritis: an analysis of 29 operated patients. Thorac Cardiovasc Surg. 1986;34:176–181
  11. Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21(6 suppl 32):S23–S28
  12. Oldenburg HS, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, et al. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response. Cytokine. 1995;7:510–516
  13. Kramer F, Torzewski J, Kamenz J, Veit K, Hombach V, Dedio J, et al. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop. Mol Immunol. 2008;45:2678–2689
  14. Kim H, Baumann H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol Cell Biol. 1999;19:5326–5338
  15. Baumann H, Gauldie J. Regulation of acute plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990;7:147–159
  16. Tompson D, Milford-Ward A, Whicher JT. The value of acute phase measurements in clinical practice. Ann Clin Biochem. 1992;29:123–131
  17. Koenig W, Lowel H, Baumert J, Meisinger C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation. 2004;109:1349–1353
  18. Gomes MB, Piccirillo LJ, Nogueira VG, Matos HJ. Acute-phase proteins among patients with type 1 diabetes. Diabetes Metab. 2003;29:405–411
  19. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis (A study of 32 North American patients). Medicine (Baltimore). 1985;64:89–99
  20. Park MC, Lee SW, Park YB, Chung NS, Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005;34:284–292
  21. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu's arteritis. Ann intern Med. 1994;120:919–929
  22. Lagneau P, Michel JP, Vuong PN. Surgical treatment of Takayasu's disease. Ann Surgery. 1987;205:157–166
  23. Badlato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994;180:203–209
  24. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest. 1998;78:535–539
  25. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, et al. Matrix metalloproteinases as a novel disease marker in Takayasu's arteritis. Circulation. 2003;108:1496-73
  26. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am. 1995;21:1041–1058

 Competition of interest: none.

 The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.

PII: S0741-5214(09)01926-0

doi: 10.1016/j.jvs.2009.09.038

Journal of Vascular Surgery
Volume 51, Issue 3 , Pages 700-706 , March 2010

Article Tools

* Image Usage & Resolution